X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (319) 319
Publication (22) 22
Book Chapter (7) 7
Book / eBook (5) 5
Conference Proceeding (5) 5
Book Review (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (180) 180
endocrinology & metabolism (133) 133
index medicus (91) 91
male (83) 83
female (80) 80
animals (71) 71
adult (62) 62
middle aged (58) 58
somatostatin - analogs & derivatives (49) 49
receptors, somatostatin - metabolism (47) 47
somatostatin (41) 41
tumors (41) 41
aged (40) 40
in-vitro (40) 40
expression (39) 39
oncology (38) 38
rats (37) 37
octreotide (36) 36
somatostatin - pharmacology (29) 29
immunohistochemistry (26) 26
octreotide - pharmacology (26) 26
receptors, somatostatin - genetics (26) 26
tumor cells, cultured (25) 25
cell line, tumor (23) 23
cells, cultured (23) 23
growth-hormone (23) 23
cancer (22) 22
pituitary neoplasms - metabolism (21) 21
abridged index medicus (20) 20
pituitary neoplasms - drug therapy (20) 20
gene expression (19) 19
research (19) 19
somatostatin - therapeutic use (19) 19
neuroendocrine tumors (18) 18
octreotide - therapeutic use (18) 18
secretion (18) 18
adenoma - metabolism (17) 17
diagnosis (17) 17
cells (16) 16
growth (16) 16
mice (16) 16
octreotide - analogs & derivatives (16) 16
receptor (16) 16
receptors, somatostatin - physiology (16) 16
reverse transcriptase polymerase chain reaction (16) 16
adenoma - drug therapy (15) 15
cell biology (15) 15
gene-expression (15) 15
insulin (15) 15
internal medicine (15) 15
pituitary neoplasms - pathology (15) 15
rna, messenger - metabolism (15) 15
surgery (15) 15
therapy (15) 15
dopamine (14) 14
dose-response relationship, drug (14) 14
pituitary (14) 14
adenomas (13) 13
cell proliferation - drug effects (13) 13
hormone (13) 13
localization (13) 13
pancreatic neoplasms - pathology (13) 13
radionuclide imaging (13) 13
receptors (13) 13
acth (12) 12
adolescent (12) 12
adrenocorticotropic hormone - metabolism (12) 12
insulin - blood (12) 12
medicine & public health (12) 12
subtypes (12) 12
treatment outcome (12) 12
young adult (12) 12
adenoma - pathology (11) 11
carcinoma (11) 11
diabetes (11) 11
dopamine agonists - therapeutic use (11) 11
health aspects (11) 11
immunohistochemical localization (11) 11
insulin-like growth factor i - metabolism (11) 11
iodine radioisotopes (11) 11
neurosciences (11) 11
octreotide - metabolism (11) 11
pancreatic neoplasms - metabolism (11) 11
pituitary acth hypersecretion - drug therapy (11) 11
rna, messenger - analysis (11) 11
somatostatin - metabolism (11) 11
acromegaly - drug therapy (10) 10
apoptosis (10) 10
apoptosis - drug effects (10) 10
cushings-disease (10) 10
endocrinology (10) 10
in vitro techniques (10) 10
management (10) 10
peptide (10) 10
pharmacology & pharmacy (10) 10
physiological aspects (10) 10
physiology (10) 10
pituitary-adenomas (10) 10
receptors, somatostatin - analysis (10) 10
scintigraphy (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
OISE - Missing (1) 1
OISE - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European journal of endocrinology, 08/2019
Octreotide remains 40 years after its development a drug, which is commonly used in the treatment of acromegaly and GEP-NETs. Very little innovation that... 
Journal Article
Journal Article
Neuroendocrinology: international journal for basic and clinical studies on neuroendocrine relationships, ISSN 0028-3835, 09/2010, Volume 92, Issue SUPPL. 1, pp. 111 - 115
Conference Proceeding
EUROPEAN JOURNAL OF ENDOCRINOLOGY, ISSN 0804-4643, 08/2019, Volume 181, Issue 2, pp. K21 - K27
Prolactinomas are the most commonly encountered pituitary adenomas in the clinical setting. While most can be controlled by dopamine agonists, a subset of... 
DIAGNOSIS | SOMATOSTATIN ANALOGS | MANAGEMENT | CABERGOLINE | GUIDELINES | ENDOCRINOLOGY & METABOLISM | CLASSIFICATION | EXPRESSION | TUMORS | SOCIETY | PITUITARY-ADENOMAS | Dopamine | Prolactin | Pituitary | Antitumor activity | Degeneration | Radiation therapy | Somatostatin | Adenoma | Temozolomide | Neurosurgery | Tumors | Necrosis
Journal Article
Journal of Cellular and Molecular Medicine: a journal of translational medicine, ISSN 1582-1838, 03/2014, Volume 18, Issue 3, pp. 492 - 502
textabstractPancreatic cancer is a highly aggressive malignancy with limited treatment options. Type-I interferons (e.g. IFN-α/-β) have several anti-tumour... 
2c | pancreatic cancer | Type‐I interferons | anti‐cancer effects | IFNAR | IFNAR-2c | IFNAR-1 | Type-I interferons | Pancreatic cancer | Anti-cancer effects | PANCREATICODUODENECTOMY | MEDICINE, RESEARCH & EXPERIMENTAL | RESECTION | ALPHA | GEMCITABINE | CELL BIOLOGY | PHASE-III TRIAL | IFN-BETA | 5-FLUOROURACIL | ADJUVANT CHEMORADIATION THERAPY | PHARMACOKINETICS | GROWTH | anti-cancer effects | Interferon-alpha - pharmacology | Apoptosis - drug effects | Humans | Pancreatic Neoplasms - pathology | RNA, Messenger - genetics | Apoptosis - genetics | Pancreatic Neoplasms - genetics | Recombinant Proteins - pharmacology | RNA, Messenger - metabolism | Blotting, Western | Interferon beta-1a | Interferon-beta - pharmacology | Cell Line, Tumor | Inhibitory Concentration 50 | Cell Proliferation - drug effects | Receptor, Interferon alpha-beta - genetics | Gene Expression Regulation, Neoplastic - drug effects | Receptor, Interferon alpha-beta - metabolism | Biological response modifiers | Interferon | Cell proliferation | Biotechnology | Multiple sclerosis | Statistical analysis | Incubation | mRNA | Malignancy | Tumor cell lines | Radiation therapy | Gene expression | Proteins | Studies | Receptors | Cell growth | Medical prognosis | Cell lines | Penicillin | Cell cycle | Deoxyribonucleic acid--DNA | Tumors | Apoptosis | Cancer | Original
Journal Article
ENDOCRINE-RELATED CANCER, ISSN 1351-0088, 06/2019, Volume 26, Issue 6, pp. 585 - 599
Control of symptoms related to hormonal hypersecretion by functioning neuroendocrine tumors (NETs) is challenging. New therapeutic options are required. Since... 
OCTREOTIDE | hormone secretion | somatostatin-dopamine chimeric drugs | NEOPLASMS | ENETS CONSENSUS GUIDELINES | LUNG CARCINOIDS | SPHEROIDS | ONCOLOGY | RECEPTOR LIGANDS | CABERGOLINE | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | PITUITARY | SECRETION | 3D cell cultures | neuroendocrine tumors
Journal Article
Journal Article
BMC CANCER, ISSN 1471-2407, 04/2019, Volume 19, Issue 1, pp. 325 - 8
Journal Article
Frontiers in Immunology, ISSN 1664-3224, 07/2017, Volume 8, p. 822
Immunosuppressive drug therapy is required to treat patients with autoimmune disease and patients who have undergone organ transplantation. The main targets of... 
Epigenetics | Transplantation immunology | Interferon-gamma | Remethylation | In vitro | Polyclonal activation | LANDSCAPE | IMMUNOLOGY | epigenetics | transplantation immunology | remethylation | MEMORY | DEMETHYLATION | REJECTION | in vitro | GENE-EXPRESSION | polyclonal activation | IMMUNOSUPPRESSIVE DRUGS | DIFFERENTIATION | PROMOTER | interferon-gamma | MOFETIL | LYMPHOCYTES
Journal Article